Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.

Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, Paul F, Levin N, Brandt AU, Scheel M.

Neuroimage Clin. 2018 May 8;19:538-550. doi: 10.1016/j.nicl.2018.05.004. eCollection 2018.

2.

Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis.

Backner Y, Kuchling J, Massarwa S, Oberwahrenbrock T, Finke C, Bellmann-Strobl J, Ruprecht K, Brandt AU, Zimmermann H, Raz N, Paul F, Levin N.

JAMA Neurol. 2018 Mar 1;75(3):287-295. doi: 10.1001/jamaneurol.2017.3880.

PMID:
29297053
3.

Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Kuchling J, Brandt AU, Paul F, Scheel M.

EPMA J. 2017 Jul 25;8(3):279-294. doi: 10.1007/s13167-017-0102-x. eCollection 2017 Sep. Review.

4.

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.

Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 22;4(3):e334. doi: 10.1212/NXI.0000000000000334. eCollection 2017 May.

5.

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.

Mikolajczak J, Zimmermann H, Kheirkhah A, Kadas EM, Oberwahrenbrock T, Muller R, Ren A, Kuchling J, Dietze H, Prüss H, Paul F, Hamrah P, Brandt AU.

Mult Scler. 2017 Dec;23(14):1847-1853. doi: 10.1177/1352458516677590. Epub 2016 Nov 3.

PMID:
27811337
6.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 27;13(1):280.

7.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 26;13(1):279.

8.

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.

Finke C, Heine J, Pache F, Lacheta A, Borisow N, Kuchling J, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e229. doi: 10.1212/NXI.0000000000000229. eCollection 2016 Jun.

9.

Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Pache F, Zimmermann H, Finke C, Lacheta A, Papazoglou S, Kuchling J, Wuerfel J, Hamm B, Ruprecht K, Paul F, Brandt AU, Scheel M.

Eur Radiol. 2016 Dec;26(12):4413-4422. Epub 2016 Mar 24.

PMID:
27012555
10.

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.

Sinnecker T, Kuchling J, Dusek P, Dörr J, Niendorf T, Paul F, Wuerfel J.

EPMA J. 2015 Aug 27;6(1):16. doi: 10.1186/s13167-015-0038-y. eCollection 2015. Review.

11.

Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.

Bozin I, Ge Y, Kuchling J, Dusek P, Chawla S, Harms L, Ruprecht K, Niendorf T, Paul F, Kister I, Sinnecker T, Wuerfel J.

PLoS One. 2015 Jul 17;10(7):e0128386. doi: 10.1371/journal.pone.0128386. eCollection 2015.

12.

GAD Antibody-Associated Late-Onset Cerebellar Ataxia in Two Female Siblings.

Kuchling J, Shababi-Klein J, Nümann A, Gerischer LM, Harms L, Prüss H.

Case Rep Neurol. 2014 Nov 26;6(3):264-70. doi: 10.1159/000369784. eCollection 2014 Sep.

13.

Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.

Müller K, Kuchling J, Dörr J, Harms L, Ruprecht K, Niendorf T, Wuerfel J, Paul F, Sinnecker T.

J Neurol. 2014 Oct;261(10):2032-6. doi: 10.1007/s00415-014-7460-2. Epub 2014 Aug 14.

PMID:
25119839
14.

Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.

Kuchling J, Ramien C, Bozin I, Dörr J, Harms L, Rosche B, Niendorf T, Paul F, Sinnecker T, Wuerfel J.

Mult Scler. 2014 Dec;20(14):1866-71. doi: 10.1177/1352458514531084. Epub 2014 Apr 29.

PMID:
24781284
15.

[Ultrahigh field MRI in context of neurological diseases].

Kuchling J, Sinnecker T, Bozin I, Dörr J, Madai VI, Sobesky J, Niendorf T, Paul F, Wuerfel J.

Nervenarzt. 2014 Apr;85(4):445-58. doi: 10.1007/s00115-013-3967-5. Review. German.

PMID:
24549692

Supplemental Content

Loading ...
Support Center